Form 4 for NAUT Nautilus Biotechnology, Inc.
Accepted 2021-12-02 00:00:00 ET · period of report 2021-11-30 · accession 0001808805-21-000027 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2021-12-02 | 2021-11-30+ | NAUT | Patel Sujal M | CEO, Pres, Sec, Dir, 10% | P - Purchase | $4.72 | +250.0K | 9.86M | +3% | +$1.18M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-11-30 | P | A | 161,978 | $4.72 | 9,776,366 | D | — | — | (F1) Represents the weighted average share price of an aggregate total of 161,978 shares purchased in the price range of $4.48 to $4.85 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price. |
| 2 | Common | Common Stock | 2021-12-01 | P | A | 88,022 | $4.73 | 9,864,388 | D | — | — | (F2) Represents the weighted average share price of an aggregate total of 88,022 shares purchased in the price range of $4.44 to $5.00 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price. |